Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Glioblastoma
100%
Temozolomide
76%
Methylguanine Methyltransferase
51%
Glioblastoma multiforme
44%
Tumor
40%
Patient-derived Xenograft
32%
Temozolomide Resistance
29%
Glioblastoma Xenografts
28%
Xenograft
26%
Blood-brain Barrier
25%
Urokinase-type Plasminogen Activator
18%
Chromosome 19
18%
Radiation Therapy
18%
Brain Tumor
17%
Glioma
17%
Glioma Patients
16%
Malignant Glioma
15%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
14%
P300
14%
ETS1
13%
Glioma Cell Lines
12%
Malignant Potential
12%
O6-methylguanine-DNA Methyltransferase
12%
Chemoresistance
12%
ETS1 Transcription Factor
12%
Immunohistochemical Expression
12%
Xenograft Model
12%
Astrocytic Tumor
12%
Antibody-drug Conjugate
12%
Targeting Antibodies
12%
Retinoblastoma Binding Protein 4
12%
Belantamab Mafodotin
12%
RBBP4
12%
Glioblastoma Cells
9%
Promoter Methylation
9%
Erlotinib
9%
Isocitrate Dehydrogenase 1 (IDH1)
9%
Methylation-specific Polymerase Chain Reaction
9%
Temozolomide Therapy
9%
Genetic Modification
9%
Homologous Recombination
9%
MGMT Promoter Methylation
8%
Temozolomide Sensitivity
8%
DNA Repair Enzymes
8%
Neuro-oncology
8%
Median Survival
8%
Oligodendroglioma
8%
IDH-mutant Glioma
8%
Chemotherapy
7%
PARP Inhibitors (PARPi)
7%
Neuroscience
Temozolomide
72%
Glioma
43%
DNA Methyltransferase
27%
Glioblastoma Multiforme
24%
Promoter Region
19%
Blood Brain Barrier
18%
Urokinase
18%
Methylation
15%
In Vitro
12%
Transcription Factor Ets 1
12%
Chemotherapy
11%
Astrocytoma
10%
Cell Line
10%
Homologous Recombination
9%
Polymerase Chain Reaction
8%
DNA Repair
7%
Gene Mutation
7%
Gene Expression
7%
Programmed Cell Death
7%
Radiation Therapy
6%
Poly ADP Ribose Polymerase
6%
Cell Growth
6%
PARP Inhibitor
6%
Cell Survival
6%
Fluorine-18
6%
Genetics
6%
Epidermal Growth Factor Receptor
6%
Alkylation
6%
Histone
6%
Carisoprodol
6%
Phenylalanine
6%
Autophagy
6%
Ran Protein
6%
Proto Oncogene
6%
Basic Fibroblast Growth Factor
6%
Protein Complexes
6%
Drug Resistance
6%
Phosphoinositide 3-Kinase
6%
6-O-Methylguanine
6%
Human Chromosome
6%
Meningioma
6%
Stem Cell
6%
Microtubules
6%
Survivin
6%
Chromosome 19
6%
Enhancer Region
6%
Protein MDM2
6%
Amino Acid Transporter
6%
Retinoblastoma Binding Protein 4
6%
Methyltransferase
6%
Medicine and Dentistry
Glioblastoma
72%
Xenograft
49%
Temozolomide
35%
Intracranial Tumor
17%
Radiation Therapy
16%
Ganglioglioma
13%
Neoplasm
13%
Tumor
10%
Methylation
10%
Epidermal Growth Factor Receptor
9%
Promoter Region
9%
Erlotinib
9%
Neuro-Oncology
8%
DNA Methyltransferase
8%
Methylated DNA Protein Cysteine Methyltransferase
7%
Gene Mutation
7%
Treatment Group
6%
Cancer Therapy
6%
Genetics
6%
Polymerase Chain Reaction
6%
Central Nervous System Tumor
6%
Biological Marker
6%
Veliparib
6%
Programmed Cell Death
6%
Apoplexy
6%
P16
6%
Artery Injury
6%
Cyclin Dependent Kinase Inhibitor
6%
Phosphoinositide 3-Kinase
6%
Carotid Artery Stenosis
6%
Epidural Hematoma
6%
Fluorine-18
6%
Phenylalanine
6%
Methyltransferase
6%
Lisavanbulin
6%
Autophagy
6%
N-Acetylcysteine
6%
Alternative Complement Pathway C3 C5 Convertase
6%
Intimal Hyperplasia
6%
Microtubule
6%
Everolimus
6%
Bone Metastasis
6%
Hepatocellular Carcinoma
6%
Amino Acid Transporter
6%
Nuclear Factor
6%
Palbociclib
6%
